|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 7/27/17 BioCrude Technologies USA, Inc. 8-A12G 1:20K S2 Filings LLC/FA |
Document/Exhibit Description Pages Size 1: 8-A12G Registration of a Class of Securities HTML 11K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BIOCRUDE TECHNOLOGIES USA, INC.
(Exact name of registrant as specified in its charter)
| Nevada | 81-2924160 | |
| (State of Incorporation or organization) | (IRS Employer Identification No.) | |
| 1255 PHILLIPS SQUARE, SUITE 605 | MONTREAL, QUEBEC, CANADA H3B 3G5 | |
| (Address of principal executive offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title
of each class |
Name
of each exchange on which each class is to be registered |
| Not Applicable |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A. (c), check the following box. ☐
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A. (d), check the following box. ☒
Securities Act registration statement file number to which this form relates:
Securities to be registered pursuant to Section 12(g) of the Act: 333-214853
Title
of each class |
Name
of each exchange on which each class is to be registered |
| 75,000,000 Shares of Common Stock | OTC |
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant’s Securities to be Registered
Common Stock, 75,000,000 Shares authorized par value $0.001.
Item 2. Exhibits
None.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
| Date: July 27, 2017 | By: | Biocrude Technologies USA, Inc.
/s/ John Moukas | |
| John Moukas | |||
| Chief Executive Officer | |||
| (Principal Executive Officer and duly authorized signatory) |
| This ‘8-A12G’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 7/27/17 | None on these Dates | ||
| List all Filings | ||||